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Abstract 
An isocratic ion pair RP-HPLC method with UV-Vis detection has been 
developed and validated for simultaneous analysis of 4-nitrophenol (PNP), 
4-nitrophenyl β-glucuronide (PNP-G), and 4-nitrophenyl sulfate (PNP-S) in rat 
bile samples using 4-ethylphenol (ETP) as internal standard. Chromatographic 
separation was achieved on a C18 column by isocratic elution with a mobile 
phase consisted of methanol-0.01 M citrate buffer pH 6.2 (47:53 v/v) containing 
0.03 M TBAB. The flow rate was 1.0 ml min
−1, the detection was affected at 290 
nm. Calibration plots were generated over the concentration range 1–100 μM 
PNP, PNP-G, PNP-S with a common lower limit of quantification of 2.5 μM. 
Intra- and inter-day precision and repeatability were determined at six different 
concentrations. Results obtained by application of the method for determination 
of PNP, PNP-G and PNP-S in bile fractions collected during intestinal perfusion 
of PNP in hyperglycemic rats are presented. 
Keywords 
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Introduction 
After oral administration of the phenolic compounds, the hepatic and intestinal glucuronic 
acid and sulfate conjugations have the most important roles as metabolic transformations 
[1]. 4-Nitrophenol (PNP) is excreted almost exclusively as its glucuronide (PNP-G) and 
sulfate (PNP-S) (Fig. 1) [2, 3].  Because of its simple and well characterized metabolic 838  A. Almási, E. Fischer, and P. Perjési:   
Sci Pharm. 2011; 79: 837–847 
profile PNP is widely used as a model substrate to evaluate the influence of diseases, 
nutrient deficiencies and other physiologically altered conditions on conjugative drug 
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Fig. 1.   Structure of 4-nitrophenol (PNP), 4-nitrophenyl β-glucuronide (PNP-G), 
4-nitrophenyl sulfate (PNP-S) and 4-ethylphenol (ETP) 
Earlier we set up an in vivo experimental protocol for investigation of intestinal metabolism 
of 4-nitrophenol (PNP) in control and hyperglycemic rats [7]. In the course of our studies, 
an isocratic ion-pair reversed phase HPLC (RP-HPLC) assay coupled with UV detection 
for simultaneous determination of PNP, PNP-G and PNP-S in the intestinal perfusates has 
been developed [8]. As a continuation of our work in this field we have developed a 
modified isocratic ion-pair RP-HPLC-UV method using 4-ethylphenol (ETP) as internal 
standard  to quantify  PNP and its metabolites in the bile samples of the experimental 
animals. This work describes details (focusing on linearity, within-day precision and day-to-
day precision) of the optimized easy to run reversed phase HPLC-UV assay to quantify 
4-nitrophenol (PNP), 4-nitrophenyl  β-glucuronide (PNP-G) and 4-nitrophenyl  sulfate 
(PNP-S) in a large number of samples generated in animal experiments. 
Results and Discussion 
Results 
The optimized RP-HPLC assay using a mobile phase of methanol-0.01 M citrate buffer pH 
6.2 (47:53, v/v) containing 0.03 M tetrabutyl-ammonium-bromide (TBAB) provided baseline 
separation of PNP, PNP-G, PNP-S and ETP in less than 14 min of chromatographic time 
(Figure 2). This analysis time was shorter than those of the previously published isocratic 
methods for determination [9–12].  Using  UV  detection  at  λ  =  290  nm,  the  optimized 
wavelength for simultaneous detection of PNP, PNP-G, PNP-S, ETP, chromatograms of 
the blank perfusates and those of the control bile samples did not show any interfering 
peaks. 
Reproducibility of retention times and integrated peak areas was determined by analysis of 
six different concentrations of PNP, PNP-G and PNP-S. Standard solutions were prepared 
by addition of known concentration of each solute to drug free perfusate. Each concen-
tration was analyzed five times. The percent RSD values found for within-day retention 
times and integrated peak areas of the standard solutions are shown in Tables 1–3.   HPLC Quantification of 4-Nitrophenol and its Conjugated Metabolites from Bile  839 
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Fig. 2.   HPLC chromatogram of 4-nitrophenol (PNP) (2), 4-nitrophenyl β-glucuronide 
(PNP-G) (1), 4-nitrophenyl sulfate (PNP-S) (3) and 4-ethylphenol (ETP) (4). 
Tab. 1.   Within day and day-to day precisions of retention times and peak areas of PNP 
in standard solution. (The precisions of the peak areas were calculated from the 
ratios of the peak areas of PNP and ETP) 
Concentration  
of standard  
solution (μM)  
PNP 
Within-day  
precision of  
retention times  












(RSD, %) (n=5) 
2.5  1.15  5.59  3.31  4.77 
5  1.05  5.49  3.47  4.31 
10  1.40  4.93  3.39  1.31 
25  2.13  4.87  3.71  2.26 
50  1.72  1.88  3.57  2.83 
100  1.01  1.77  4.04  0.86 
 
Tab. 2.   Within day and day-to day precisions of retention times and peak areas of PNP-
G in standard solution. (The precisions of the peak areas were calculated from 







retention times  
(RSD, %) (n=5) 
Within-day 
precision of 
peak areas  








(RSD, %) (n=5) 
2.5  0.50  4.96  1.26  1.30 
5  0.50  4.61  1.28  2.44 
10  0.45  4.40  1.17  1.34 
25  0.42  4.19  1.69  1.64 
50  0.51  1.40  1.33  2.02 
100  0.57  1.63  1.51  0.79 840  A. Almási, E. Fischer, and P. Perjési:   
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Tab. 3.   Within day and day-to day precisions of retention times and peak areas of PNP-
S in standard solution. (The precisions of the peak areas were calculated from 




















(RSD, %) (n=5) 
2.5  0.83  4.21  3.34  2.40 
5  0.92  3.30  3.30  2.88 
10  1.04  3.42  3.21  2.68 
25  1.02  3.50  3.25  2.58 
50  1.41  3.36  3.34  2.41 
100  1.23  3.48  3.79  0.57 
 
Linear response was obtained for the calibration of all three compounds in the target 
concentration range of 2.5–100 μM (n = 6). The calibration ranges were chosen based on 
the expected solute concentrations in the bile [7].  
The obtained calibration equations (with r
2 values) were:  
y = 0.0142 x − 0.0021 (1.000) for PNP-G 
y = 0.0080 x − 0.0007 (1.000) for PNP 
y = 0.0142 x − 0.0007 (0.9999) for PNP-S 
Precision of both retention times (RSD = 0.42–4.04%) and the integrated peak areas (RSD 
= 0.57–5.49%) were found to be acceptable. 
ETP gave a linear response in the concentration range of 1–5 mM (n = 6). The calibration 
equation for this range (with r
2 value) was found to be  
y = 1.9247 x − 0.0917 (0.9994).  
Precision of the integrated peak areas (RSD = 0.44–3.71%) and that of the retention times 
(RSD = 3.71–4.14%) were found to be satisfactory. 
For the calibration curves obtained for PNP, PNP-G and PNP-S the percentage relative 
standard error (%RSD) of the slopes were 2.57%, 2.93% and 3.04%, respectively. Based 
on the calculation of the root mean square error (RMSE) over the 2.5–25.0 μM (PNP-G 
and PNP-S) concentration ranges, the instrumental quantification limit (calculated as 
(10xRMSE)/m, where m is the slope of the calibration curve [13]) for the PNP-G and 
PNP-S was found to be 2.7 μM and 2.1 μM, respectively. 
For determination of day-to-day precision of retention times and integrated peak areas, 
one set of calibration samples with the same PNP, PNP-G and PNP-S content was 
prepared and measured on the same  working day over five consecutive weeks. The 
percentage RSD values for retention time and integration areas obtained from the 
measurements are summarized in Tables 1–3.   HPLC Quantification of 4-Nitrophenol and its Conjugated Metabolites from Bile  841 
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The method described above has been applied to determination of PNP and the two PNP 
conjugates in the bile samples of the rat. The concentrations of PNP, PNP-G and PNP-S 
in the samples were determined by standard curves described above. The graphical 
representations of the results are shown on Figures 3–5. Each value represents the mean 
± standard error (n=8). 
Discussion 
In order to set up a simple, easy to perform assay to quantify PNP and its conjugates in 
the rat bile samples, we considered only isocratic RP-HPLC methods that can provide a 
straightforward and time-consuming separation of PNP and both of its glucuronide 
(PNP-G) and sulfate (PNP-S) conjugates. Earlier Karakaya and Carter reported on 
separation of glucuronide and sulfate conjugates of 4-nitrophenol and 1-naphtol using 
methanol-water mixtures of different compositions containing 0.01 M TBAB as eluent [14]. 
The authors found that the two more acidic conjugates (pKa (PNP-S) 4 [15], pKa (PNP-G) 
3.0–3.4 [16]) and the weak acid parent PNP (pKa = 7.14 [17]) could be well separated 
without precise adjustment of the pH of the eluent. Due to the acid-base character and the 
presence of other components of the bile, however, in the present work we applied a 
buffer for the precious setting of the pH, and increased the quantity of TBAB, the ion-
pairing reagent. To further improve precision of the method, an internal standard (ETP) 
was applied. 
During our preliminary investigations we have performed chromatographic analysis of a 
mixture of PNP, PNP-G, PNP-S and ETP (100 mM each) using a mobile phase methanol-
0.01 M citrate buffer (47:53, v/v) containing 0.03 M TBAB. It was found that the integrated 
areas remained unchanged when the pH of the mobile phase was 3.5, 4.0, 5.0 and 6.2 but 
the k values of PNP and PNP-S was found to be appropriate for baseline separation only 
at pH 6.2. Under the optimum pH conditions both PNP-G and PNP-S exist practically fully 
ionized, which is the appropriate form of the polar species to form ion pairs with TBAB 
adsorbed onto the RP stationary phase [18]. 
The method described above has been applied to the determination of PNP and the PNP 
conjugates (PNP-G and PNP-S) in rat bile samples. The amount of the excreted PNP and 
its conjugates was determined in control and streptozotocin-treated animals. 
Streptozotocin  (STZ)  destroys  the  insulin  producing  β-cells in the pancreas, causing a 
diabetes-like status (hyperglycemia) to the experimental animals [19].  In comparison, 
determination of the amount of the three compounds has been also performed in bile 
samples of STZ plus insulin-treated animals. Changes in the excreted amount of PNP, 
PNP-G and PNP-S in the bile of the rat during perfusion of the jejunal loop with isotonic 
medium containing 500 µM PNP are demonstrated on Figures 3–5. 
As it is shown in Figure 3, the STZ treatment depressed the bile excretion of PNP. The 
depression was not influenced by the rapid-acting insulin (Actrapid); however, the 
intermediate-acting insulin (Humulin N) was able to compensate the decrease of biliary 
excretion of PNP. The STZ treatment decreased excretion to the bile of the PNP-G 
metabolite as well. The insulin treatments elevated the levels of the metabolite to those of 
the control (Figure 4). 842  A. Almási, E. Fischer, and P. Perjési:   
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Fig. 3.   Change in excreted amount of PNP in the bile of the rat during perfusion of the 
jejunal loop with isotonic medium containing 500 µM PNP. Each value 
represents the average of eight independent experiments ± standard error. 
Details of measurements are written in the Experimental part. 
 
Fig. 4.   Change in excreted amount of PNP-G in the bile of the rat during perfusion of 
the jejunal loop with isotonic medium containing 500 µM PNP. Each value 
represents the average of eight independent experiments ± standard error. 
Details of measurements are written in the Experimental part. 
The experimental diabetes caused by STZ also decreased the PNP-S in the rat bile, and 
the insulin treatments were not able to compensate this reduction (Figure 5). 
In conclusion, the ion pair reversed phase HPLC method with UV detection provided 
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day precision (repeatability), day-to-day precision (reproducibility) and linearity. The 
method has proved to be simple and easy-to-perform for determination of PNP, PNP-G 
and PNP-S in the rat bile samples. 
 
Fig. 5.  Change in excreted amount of PNP-S in the bile of the rat during perfusion of 
the jejunal loop with isotonic medium containing 500 µM PNP. Each value 
represents the average of eight independent experiments ± standard error. 
Details of measurements are written in the Experimental part. 
Experimental 
Chemicals 
4-Nitrophenol (PNP), 4-nitropheny β-glucuronide (PNP-G), 4-nitrophenyl sulfate (PNP-S), 
4-ethylphenol (ETP), streptozotocin (STZ) and tetrabutylammonium bromide (TBAB) were 
obtained from Sigma-Aldrich (Budapest, Hungary). The structures of PNP, PNP-G, PNP-S 
and ETP are shown on Figure 1. Actrapid (40 IU/ml rapid-acting insulin) and Humulin N 
(intermediate-acting insulin) were obtained from Novo Nordisk Hungaria (Budapest, 
Hungary) and Lilly Hungaria (Budapest, Hungary), respectively. All solvents were HPLC 
grade. 
HPLC conditions and instrumentation 
The HPLC system consisted of a Varian 2010 pump, a Rheodyne 7725i injection valve, a 
UV-Detector 308 (Labor MIM, Budapest, Hungary) UV-Vis detector. Data were collected 
and integrated using a PowerChrom 280 data module and software (ADInstruments, 
Sydney, Australia). A Nucleosil 100 C18 reversed phase column (250 mm x 4.6 mm I.D., 
10  μm  particle  size),  and  a  TR-C-160K1 ODS guard column (Teknokroma, Barcelona, 
Spain) were employed for all separations. UV measurements were performed on a 
Secomam Anthelie Light UV-Vis spectrophotometer (Secomam, Ales, France) at ambient 
temperature. A Mettler Toledo MP 220 pH meter and a Mettler Toledo Inlab 413 electrode 
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Analytical conditions 
The mobile phase used consisted of methanol-0.01 M citrate buffer pH 6.2 (47:53, v/v) 
containing 0.03 M TBAB. The pH of the eluent was adjusted with 1 M HCl solution. The 
sample volume was 20 μl, the flow rate was 1.0 ml min
−1 and detection was affected at 
290 nm, the wavelength that was found to be the optimum for simultaneous detection of 
PNP, PNP-S, PNP-G and ETP. The analyses were performed at ambient temperature 
allowing a 15 min equilibration after the start of pumping mobile phase through the column. 
The retention factors (k) of PNP-G, PNP, PNP-S and ETP were 0.86, 2.51, 3.42 and 4.63, 
respectively. 
Calibration curves 
Standard solutions were prepared by addition of known concentrations (1–100 μM) of each 
solute (PNP, PNP-G, PNP-S) and ETP (2.5 mM) to the eluent. Calibration curves were 
constructed based on the ratio of integrated peak areas of the solutes and that of the 
internal standard. For each solute a linear relationship was found in the 2.5–100 µM 
concentration range. 
Precision of method 
Five replicate injections were made of the standard solutions. The relative standard 
deviation (RSD) of retention times and peak areas was calculated to assess intra-day 
precision. The same refrigerated (4 °C) solutions were used to prepare the standard curve 
for five consecutive days and the RSD values calculated to assess inter-day assay 
variations. 
Animal experiments 
Hyperglycemia was induced in male Wistar rats (weighting 220-250 g) by i.v. 
administration of STZ in a dose of 65 mg/kg. After 1 week of the STZ treatment animals 
were anaesthetized with urethane (1.2 g/kg, i.p.). One group of the animals was treated 
with rapid-acting insulin (Actrapid) (1 IU/kg, i.m.) just before the anesthesia. A second 
group of the animals was treated with intermediate-acting insulin (Humulin N) (2 x15 IU, 
i.p.) every day for one week after the STZ treatment.  
The jejunal loop and the bile duct of the anaesthetized rats were cannulated and the lumen 
of the small intestine was perfused with isotonic medium containing 500 μM PNP at a rate 
of  13  mL/min  in  recirculation  mode.  Samples  (250  μL  each)  were  obtained  from  the 
perfusion medium coming out from the jejunal loop. Bile was collected in 15 min periods 
into Eppendorf tubes placed in ice. The rate of the bile flow changed between 37.6±9.95 to 
103.1±11.5 (μl/kg/min). The collected samples were stored in refrigerator (−20 °C) until 
analysis. 
All procedures were carried out on animals according to the Hungarian Animals Act 
(Scientific Procedures, 1998), and the study was approved by the Ethics Committee on 
Animal Research of the University of Pécs. 
Sample preparation 
Before analysis, temperature of the samples was allowed to rise to ambient temperature, 
and the perfusates were vortexed for 10 s and centrifuged at 3000 g for 10 min. After 10 s   HPLC Quantification of 4-Nitrophenol and its Conjugated Metabolites from Bile  845 
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vortexing, 50 μl aliquot of each bile sample was taken and mixed with 200 μl of 3.125 mM 
methanolic ETP solution. The samples were vortex-mixed for 20 s and then centrifuged at 
10000 g for 10 min to sediment the precipitated protein. Each measurement represents the 
average of eight independent experiments. 
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